For: | Chao J, Bledsoe G, Chao L. Kallikrein-kinin in stem cell therapy. World J Stem Cells 2014; 6(4): 448-457 [PMID: PMC4172673 DOI: 10.4252/wjsc.v6.i4.448] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v6/i4/448.htm |
Number | Citing Articles |
1 |
Miruna Mihaela Micheu, Alina Ioana Scarlatescu, Alexandru Scafa-Udriste, Maria Dorobantu. The Winding Road of Cardiac Regeneration—Stem Cell Omics in the Spotlight. Cells 2018; 7(12): 255 doi: 10.3390/cells7120255
|
2 |
Micheli M. Pillat, Mona N. Oliveira, Helena Motaln, Barbara Breznik, Talita Glaser, Tamara T. Lah, Henning Ulrich. Glioblastoma‐mesenchymal stem cell communication modulates expression patterns of kinin receptors: Possible involvement of bradykinin in information flow. Cytometry Part A 2016; 89(4): 365 doi: 10.1002/cyto.a.22800
|
3 |
Wenjuan Liu, Robert C. Stanton, Zhaoyun Zhang. The kallikrein–kinin system in diabetic kidney disease. Current Opinion in Nephrology and Hypertension 2017; 26(5): 351 doi: 10.1097/MNH.0000000000000344
|
4 |
Shuang Gu, Qiaojia Ling, Guifeng Bao, Lin Xie, Yongqing Shi, Xiangyang Wang. Effect of Various Fruit Extracts on Angiotensin I-Converting Enzyme (ACE) and Kallikrein (KLK) Activities. Plant Foods for Human Nutrition 2024; 79(4): 860 doi: 10.1007/s11130-024-01223-5
|
5 |
Rajko Igić. Four decades of ocular renin-angiotensin and kallikrein-kinin systems (1977–2017). Experimental Eye Research 2018; 166: 74 doi: 10.1016/j.exer.2017.05.007
|
6 |
Michelle Alexander-Curtis, Rick Pauls, Julie Chao, John J Volpi, Philip M Bath, Todd A. Verdoorn. Human tissue kallikrein in the treatment of acute ischemic stroke. Therapeutic Advances in Neurological Disorders 2019; 12 doi: 10.1177/1756286418821918
|
7 |
Sooram Banesh, Surajbhan Sevda. International Encyclopedia of Public Health. 2025; : 511 doi: 10.1016/B978-0-323-99967-0.00234-9
|
8 |
Marina Devetzi, Maria Goulielmaki, Nicolas Khoury, Demetrios Spandidos, Georgia Sotiropoulou, Ioannis Christodoulou, Vassilis Zoumpourlis. Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review). International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3361
|